This contract involves the supply of various medical materials specifically for endoscopic procedures, including CPRE (Endoscopic Retrograde Cholangiopancreatography) equipment. The total value of the contract is approximately €400,935.95. The buyer is the Hospital Universitario Príncipe de Asturias
Contract awarded. Originally published 8 months ago.
No single supplier dominates the field.
In healthcare medical, PRINCE OF ASTURIAS UNIVERSITY HOSPITAL has awarded 6 contracts to 6 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the supply of antineoplastic agents in dosages of 200 mg, 150 mg, and 100 mg. The Hospital Universitario Príncipe de Asturias is seeking reliable suppliers to provide these essential medications for cancer treatment. The total value of the contract is approximately €429,350.80
The Hospital Universitario Príncipe de Asturias is seeking suppliers for surgical implants specifically designed for spinal procedures. This contract involves the provision of high-quality spinal implants to support surgical operations at the hospital. The total value of the contract is €688,280. In
The Hospital Universitario Príncipe de Asturias is seeking suppliers for the provision of immunoglobulins and immunosera. This contract, valued at approximately €2,267,397, aims to ensure the availability of these essential health products. Interested suppliers should review the details and submit t
NHS Scotland is seeking suppliers of generic and biosimilar cancer medicines to improve patient access and optimize healthcare costs.
Royal Borough of Greenwich is commissioning a School Health and Wellbeing Service to deliver preventative health and early intervention support for children and young people aged 5-19 years across the borough, with contract commencement in April 2027.
Suffolk County Council is testing market interest for postal delivery of nicotine replacement therapy and smoking cessation medications to improve accessibility for local residents.
PSD Scotland is engaging with the market to explore delivery solutions for a national Targeted Lung Cancer Screening Programme for smokers aged 55-74 in Scotland.
